Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Intraoperative avidination for radionuclide treatment as a radiotherapy boost in breast cancer: results of a phase II study with 90Y-labeled biotin
European Journal of Nuclear Medicine & Molecular Imaging, 09/23/09
Paganelli G et al. – IART plus reduced EBRT can accelerate irradiation after conservative breast surgery. Local G3 toxicity occurred in 3/32 patients during EBRT. IART plus EBRT was well accepted, with good cosmetic outcomes and maintained quality of life.
Today in Interventional...keeping you current
Receive free subspecialty "5-minute updates" via email
Ultrasound guidance for epidural steroid injections
Techniques in Regional Anesthesia and Pain Management, 11/20/09
Ultrasound and peripheral blocks for acute and chronic pain: A review
European Journal of Pain, 11/17/09
Ultrasound guidance for peripheral nerve blockade
Cochrane Reviews, 10/12/09
Today in Nuclear Medicine...keeping you current
Receive free subspecialty "5-minute updates" via email
A Comparison Between Diagnostic I-123 and Posttherapy I-131 Scans in the Detection of Remnant and Locoregional Thyroid Disease
Clinical Nuclear Medicine , 11/25/09
Comparison of 18F-Fluoro-L-DOPA, 18F-Fluoro-Deoxyglucose, and 18F-Fluorodopamine PET and 123I-MIBG Scintigraphy in the Localization of Pheochromocytoma and Paraganglioma
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Use of 18F-FDG-PET in the diagnosis of endoprosthetic loosening of knee and hip implants
Archives of Orthopaedic and Trauma Surgery, 11/10/09
Today in Radiotherapy (XRT)...keeping you current
Receive free subspecialty "5-minute updates" via email
Radiation therapy and tamoxifen after breast-conserving surgery: Updated results of a 2×2 randomised clinical trial in patients with low risk of recurrence
European Journal of Cancer, 11/05/09
Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival
The Lancet Oncology - Online First, 11/11/09
Phase I dose-finding study of paclitaxel with panitumumab, carboplatin and intensity-modulated radiotherapy in patients with locally advanced squamous cell cancer of the head and neck
Annals of Oncology, 11/10/09
Sponsor
Article Search
Sponsor


See Latest Articles


